TEVA — Teva Pharmaceutical Industries Limited Ordinary Shares
13 mentions in the last 24 hours · 0.06% of all mentions
Why people talked about TEVA (2026-11-03)
- Teva halted the TOPAS-MSA study after interim analysis signaled futility, causing the stock to dip.
- The broader emrusolmin program remains under review, but the stock price actually rose following the announcement.
- Teva announced an agreement with Samsung Bioepis to commercialize two FDA-approved biosimilars in the U.S.
| GDELT | 8 | news |
| Bluesky | 3 | community |
| Marketaux | 1 | news |
| SEC EDGAR 8-K | 1 | filings |